PECULIARITIES OF SINUS NODE PACEMAKER ACTIVITY DISREGULATION IN PATIENTS WITH ISCHEMIC HEART DISEASE, DIABETES MELLITUS AND ASSOCIATION OF THESE PATHOLOGIES

Cover Page

Cite item

Full Text

Abstract

Ключевые слова. Сахарный диабет, вариабельность ритма сердца, ишемическая болезнь сердца. Aim. The method of rhythmocardiography (RCG) was used to study the peculiarities of pacemaker activity disregulation of the sinus node of the heart in patients with ischemic heart disease (IHD), type 2 diabetes mellitus (DM2) and their association as well as to ground the significance of the associated pathology in aggravation of cardiac rhythm variability (CRV) parameters. Materials and methods. The study included patients with IHD ( n = 42), DM2 ( n = 100) and DM2+IHD ( n = 63). The groups were comparable by the age (mean age 56,9 ± 7,6 years) and gender distribution. Cardiac rhythm variability was analyzed with the method of high-performance RCG using KAP-RK-01-“Mikor” (registration certificate №FS-022б2005/2447-06). Results. The results of comparative analysis of CRV in patients with IHD ( n = 42), DM2 ( n = 100) and DM2+IHD ( n = 63) were respectively the following: total variability SDNN - 0,025 ± 0,01; 0,019 ± 0,01; 0,015 ± 0,006; root-mean-square deviations (in seconds) of humoral-metabolic σI (0,016 ± 0,006; 0,013 ± 0,007; 0,011 ± 0,005), sympathetic σm (0,010 ± 0,007; 0,008 ± 0,007; 0,005 ± 0,003) and parasympathetic waves σs (0,14 ± 0,008; 0,010 ± 0,008; 0,007 ± 0,004) and their percentage (VLF% - 58,1 ± 17,2; 56,5 ± 19,0; 48,2 ± 18,6; LF% - 13,3± 7,4; 16,4 ± 12,2; 17,9 ± 12,2; HF% - 25,6 ± 18,3; 33,8 ± 18,6; 26,9 ± 18,6). Statistically significant differences ( Z = 3,4-10,8; p < 0,05) demonstrated aggravation of CRV in DM2+IHD as compared with IHD as well as with DM2. Conclusions. More marked SN disregulations in case of DM2+IHD association as compared to those in patients with DM2 without IHD and to patients with IHD without carbohydrate metabolism disturbances were found; a negative effect of DM2 and IHD association is evident.

About the authors

E V Nuzhdina

Челябинская областная клиническая больница

Email: evgenikud12@hotmail.com
врач-эндокринолог областного эндокринологического центра

E V Davydova

Южно-Уральский государственный медицинский университет

доктор медицинских наук, профессор кафедры факультетской терапии

References

  1. Балаболкин М.И. Диабетология. М.: Медицина 2000; 672.
  2. Давыдова Е.В. Диагностика кардиопатии по данным анализа ритмокардиографии и эхокардиографии у профбольных. Медицина труда и промышленная экология 2008; 10: 20-24.
  3. Давыдова Е.В. Закономерности дисрегуляций пейсмекерной активности синусового узла сердца у больных профессиональными заболеваниями: дис. … д-ра мед. наук. Иркутск 2011; 324.
  4. Миронова Т.Ф., Миронов В.А. Вариабельность сердечного ритма при ишемической болезни сердца. Челябинск: Рекпол 2006; 136.
  5. Ткачёва О.Н., Вёрткин А.Л. Диабетическая автономная нейропатия: руководство для врачей. М.: ГЭОТАР-Медиа 2009; 176.
  6. Эндокринология: нац. руководство. Краткое издание. Под ред. И.И. Дедова, Г.А. Мельниченко. М.: ГЭОТАР-Медиа 2011; 752.
  7. Maser R.E., Mitchell B.D., Vinik A.I., Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 2003; 26: 1895-1901.
  8. Mironova T., Mironov V., Antufiev V., Safronova E., Mironov M., Davidova E. Heart rate variability analysis at coronary artery disease and angina pectoris. Recent Patents on Cardiovascular Drug Discovery 2009; 4 (1): 45-54.
  9. Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care 2010; 33 (2): 434-441.
  10. Rydén L., Ryden L., Grant P.J., Anker S.D., Berne C., Cosentino F., Danchin N. ESC Guidelines on diabetes, prediabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013; 34 (39): 3035-3087.
  11. Spallone V., Ziegler D., Freeman R., Bernardi L., Frontoni S., Pop-Busui R., Stevens M., Kempler P., Hilsted J., Tesfaye S., Low P., Valensi P. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 2011; 27: 639-653.
  12. Wu J.S., Yang Y.C., Lin T.S., Huang Y.H., Chen J.J., Lu F.H., Wu C.H., Chang C.J. Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose. J Clin Endocrinol Metab 2007; 92: 3885-3889.
  13. Ziegler D., Zentai C.P., Perz S., Rathmann W., Haastert B., Doring A., Meisinger C. Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and non-diabetic population: the MONICA/KORA Augsburg Cohort Study. Diabetes Care 2008; 31: 556-561.

Copyright (c) 2016 Nuzhdina E.V., Davydova E.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies